Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by tamarindo1on Mar 02, 2021 5:51pm
204 Views
Post# 32698311

Old Stuff

Old StuffGoin over old stuff. Sent this to: have your say@bbc.co.uk 
Sent this to the BBC over 2years ago. No reply. :-) 



Dear sir/Madam, I would like to bring to your attention a small Canadian clinical stage pharmaceutical company which may be worthy of further research by the BBC.  Although currently under the  radar their research and development of light activated compounds, (PDC’s) is nothing short of phenomenal.  Their phase 1b trial for non muscle invasive bladder cancer (NMIBC) has met with a 100% success rate
and they are currently preparing for phase 2 trials.
  Their patent protected TLD-1433 light activated drug combined with transferrin to form Rutherrin has also proven successful on Glioblastoma brain cancer (GBM) and lung cancer in Vitro and in mice. The companies name is Theralase Technologies and their press releases can be viewed at theralase.com/press-releases/.  As is most often the case small companies remain invisible until that magic eureka moment. I feel that moment is fast approaching for Theralase and may be worthy of an some attention by the BBC.
As an added incentive I would like to point out that Canada is well noted for some stunning world changing medical breakthroughs during the last century. A few to mention are: 1920, Sir Frederick Banting, (Insulin).  1950, Dr. Wilfrid Bigelow (How to lower body core temperature, making heart surgery safer).  1961, Drs. James Till and Ernest McCulloch (Their techniques applied to stem cell research & discovering transplantable stem cells).  1984, Dr. Tak Wah Mak, (His discovery of T-cell receptors, a major step in cancer immunology).
1996, Dr. Julio Montaner, (His success in turning Hiv/Aids from a death sentence to a chronic disease).  Again, in closing I am hoping that Theralase will get some well deserved attention.      Respectfully, 
<< Previous
Bullboard Posts
Next >>